Compare LBRDA & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LBRDA | BIRK |
|---|---|---|
| Founded | 2014 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | |
| Sector | Telecommunications | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 7.9B |
| IPO Year | N/A | 2023 |
| Metric | LBRDA | BIRK |
|---|---|---|
| Price | $44.39 | $39.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 14 |
| Target Price | ★ $115.00 | $63.23 |
| AVG Volume (30 Days) | 136.6K | ★ 2.8M |
| Earning Date | 02-11-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1.38 | ★ 83.10 |
| EPS | ★ 5.51 | 2.19 |
| Revenue | $1,016,000,000.00 | ★ $2,460,904,611.00 |
| Revenue This Year | N/A | $14.14 |
| Revenue Next Year | $109.28 | $14.62 |
| P/E Ratio | ★ $8.39 | $18.36 |
| Revenue Growth | ★ 306.40 | 16.22 |
| 52 Week Low | $42.69 | $36.89 |
| 52 Week High | $102.38 | $62.66 |
| Indicator | LBRDA | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 38.78 | 43.21 |
| Support Level | $42.69 | $36.89 |
| Resistance Level | $45.14 | $40.53 |
| Average True Range (ATR) | 1.57 | 1.92 |
| MACD | -0.37 | -0.31 |
| Stochastic Oscillator | 22.82 | 34.27 |
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.